Halozyme appoints Jim Daly to board of directors
HALO•Halozyme appointed James “Jim” Daly to its board of directors. Daly previously held senior commercial roles at Incyte, Amgen and Glaxo Wellcome/GlaxoSmithKline.
1. Daly joins board
Halozyme appointed James “Jim” Daly to its board of directors. He was Incyte’s executive vice president and chief commercial officer from 2012 to 2015.
2. Commercial experience
Daly spent a decade at Amgen, most recently as senior vice president for North America commercial operations, global marketing and commercial development. Earlier, he spent more than 16 years at Glaxo Wellcome/GlaxoSmithKline, including as senior vice president and general manager of the U.S. respiratory business.
